Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
3.990
+0.050 (1.27%)
At close: Dec 5, 2025, 4:00 PM EST
3.980
-0.010 (-0.25%)
After-hours: Dec 5, 2025, 7:29 PM EST
Cingulate Market Cap
Cingulate has a market cap or net worth of $26.96 million as of December 5, 2025. Its market cap has increased by 104.71% in one year.
Market Cap
26.96M
Enterprise Value
25.42M
1-Year Change
104.71%
Ranking
Category
Stock Price
$3.99
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has decreased from $64.29M to $26.96M, a decrease of -58.06%. That is a compound annual growth rate of -19.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 26.96M | 65.63% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |